"Heart Atria" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The chambers of the heart, to which the BLOOD returns from the circulation.
| Descriptor ID |
D006325
|
| MeSH Number(s) |
A07.541.358
|
| Concept/Terms |
Heart Atria- Heart Atria
- Atria, Heart
- Heart Atrium
- Atrium, Heart
|
Below are MeSH descriptors whose meaning is more general than "Heart Atria".
Below are MeSH descriptors whose meaning is more specific than "Heart Atria".
This graph shows the total number of publications written about "Heart Atria" by people in this website by year, and whether "Heart Atria" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 3 | 0 | 3 |
| 2007 | 6 | 1 | 7 |
| 2008 | 5 | 4 | 9 |
| 2009 | 5 | 2 | 7 |
| 2010 | 4 | 6 | 10 |
| 2011 | 2 | 2 | 4 |
| 2012 | 7 | 5 | 12 |
| 2013 | 1 | 2 | 3 |
| 2014 | 3 | 8 | 11 |
| 2015 | 7 | 6 | 13 |
| 2016 | 4 | 2 | 6 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 4 | 7 |
| 2019 | 3 | 2 | 5 |
| 2020 | 4 | 4 | 8 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heart Atria" by people in Profiles.
-
Intzes S, Zagoridis K, Symeonidou M, Spanoudakis E, Arya A, Dinov B, Dagres N, Hindricks G, Bollmann A, Kanoupakis E, Koutalas E, Nedios S. P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis. Europace. 2023 Feb 16; 25(2):450-459.
-
Zoghbi WA, Levine RA, Flachskampf F, Grayburn P, Gillam L, Leipsic J, Thomas JD, Kwong RY, Vandervoort P, Chandrashekhar Y. Atrial Functional Mitral Regurgitation: A JACC: Cardiovascular Imaging Expert Panel Viewpoint. JACC Cardiovasc Imaging. 2022 11; 15(11):1870-1882.
-
Ibrahim SH, Bilchick KC, Miller MS, Blazek OJ, Strickling JE, Elumogo C, Wharton RC, Patel P, Ondigi O, Brady WJ, Kwon Y, Mazimba S. Increased left and right atrial volume indices are associated with decreased survival times post-cardiac arrest. Resuscitation. 2022 01; 170:306-313.
-
Seew?ster T, Marinov K, L?be S, Knopp H, Nedios S, Bollmann A, Hindricks G, Dinov B. Abnormal pattern of left atrial activation and asynchronous conduction predicted the occurrence of new atrial fibrillation: evidences for Bachmann's bundle block in atrial fibrillation pathophysiology. Europace. 2021 08 06; 23(8):1244-1251.
-
Nedios S, Lindemann F, Heijman J, Crijns HJGM, Bollmann A, Hindricks G. Atrial remodeling and atrial fibrillation recurrence after catheter ablation : Past, present, and future developments. Herz. 2021 Aug; 46(4):312-317.
-
Nedios S, Dinov B, Seew?ster T, Lindemann F, Richter S, Arya A, Dagres N, Husser D, Bollmann A, Hindricks G, M?ssigbrodt A. Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy. Sci Rep. 2021 06 14; 11(1):12411.
-
Alloah Q, Pelletier G, Prada-Ruiz AC, Tsuda T. Rapid Growth of Left Atrial Thrombus in a Pediatric Heart Transplant Recipient. Ann Thorac Surg. 2022 02; 113(2):e133-e135.
-
Burashnikov A. Depolarization of the atrial resting membrane potential as an approach to enhance the anti-atrial fibrillation efficacy of sodium channel blockers. Heart Rhythm. 2021 07; 18(7):1221-1222.
-
Kosiuk J, Langenhan K, Hindricks G, Bollmann A, Dagres N. Remote ischemic preconditioning in a setting of electrical cardioversion of early onset persistent atrial fibrillation (RIP CAF trial): Rationale and study design. J Cardiol. 2021 01; 77(1):79-82.
-
Burashnikov A, Barajas-Martinez H, Hu D, Robinson VM, Grunnet M, Antzelevitch C. The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity. J Cardiovasc Pharmacol. 2020 08; 76(2):164-172.